Filter
1376
Text search:
drug
regimens
Featured
154
354
Language
Document type
914
192
161
39
24
21
12
7
3
2
1
Countries / Regions
77
42
38
34
33
31
26
25
25
23
22
19
18
18
17
15
14
14
13
13
12
12
12
12
11
10
10
9
9
8
7
6
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
448
226
58
53
29
13
5
Toolboxes
296
290
52
49
41
30
23
22
18
17
11
11
7
7
6
4
3
3
2
2
2
1
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr
...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
A rapid situation analysis in three districts
Joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection.
WHO clinical and policy guidelines
Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek
http://www.who.int/disabilities/cbr/guidelines/en/
